Dr. Reddy's Laboratories Limited (BOM:500124)
1,150.90
-1.70 (-0.15%)
At close: Jul 27, 2026
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,527 employees as of March 31, 2026. The number of employees decreased by 284 or -1.02% compared to the previous year.
Employees
27,527
Change (1Y)
-284
Growth (1Y)
-1.02%
Revenue / Employee
12.03M INR
Profits / Employee
1.20M INR
Market Cap
958.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 27,527 | -284 | -1.02% |
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lupin | 26,021 |
| Torrent Pharmaceuticals | 18,258 |
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 5,153 |
| Granules India | 4,306 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,679 |
Dr. Reddy's Laboratories News
- 17 hours ago - Thailand approves Nuzolvence antibiotic for gonorrhoea treatment - The Times of India
- 21 hours ago - Trump's Tariffs Are Targeting Indian Drugmakers. Americans Could Soon Pay More for Generic Medicines, CEO Warns - IBTimes
- 3 days ago - Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY) - PRNewsWire
- 4 days ago - U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns - CNBC
- 4 days ago - Dr Reddy's Laboratories Ltd (RDY) Shares Surge 3.7% -- What GF Score of 83 Tells Investors - GuruFocus
- 4 days ago - Dr Reddy's Laboratories Ltd Annual Shareholders Meeting Transcript - GuruFocus
- 5 days ago - Dr. Reddy's Laboratories Q1 Net Profit Drops As Revenue Slips, Expenses Climb - Nasdaq
- 5 days ago - U.S. pharma tariffs 'can't be absorbed' and drug prices will increase, says Dr Reddy's CEO - CNBC